Primeren kombinált oralis antidiabetikus terápia 2-es típusú diabetes mellitusban.

Translated title of the contribution: Primary combined oral antidiabetic therapy in type-2 diabetes mellitus

G. Winkler, Eva Baranyi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

New target values of the metabolic control and recent directions in the therapeutic strategies of type 2 diabetes mellitus are overviewed. Attention is called to the atherogenic effect of blood glucose elevations exceeding physiological level, even when only post-prandial and with short duration. The significance of early phase prandial insulin secretion in the metabolic state is underlined, and the related new therapeutic possibilities are discussed. Practical guidelines are given to the introduction of oral antidiabetic therapy, and the importance of the early, aggressive, combined treatment with a complex mechanism of action is emphasized.

Original languageHungarian
Pages (from-to)2441-2447
Number of pages7
JournalOrvosi Hetilap
Volume143
Issue number43
Publication statusPublished - Oct 27 2002

Fingerprint

Hypoglycemic Agents
Type 2 Diabetes Mellitus
Meals
Blood Glucose
Therapeutics
Guidelines
Insulin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Primeren kombinált oralis antidiabetikus terápia 2-es típusú diabetes mellitusban. / Winkler, G.; Baranyi, Eva.

In: Orvosi Hetilap, Vol. 143, No. 43, 27.10.2002, p. 2441-2447.

Research output: Contribution to journalArticle

@article{eee9796d92fc4d35b298877c531dcdb2,
title = "Primeren kombin{\'a}lt oralis antidiabetikus ter{\'a}pia 2-es t{\'i}pus{\'u} diabetes mellitusban.",
abstract = "New target values of the metabolic control and recent directions in the therapeutic strategies of type 2 diabetes mellitus are overviewed. Attention is called to the atherogenic effect of blood glucose elevations exceeding physiological level, even when only post-prandial and with short duration. The significance of early phase prandial insulin secretion in the metabolic state is underlined, and the related new therapeutic possibilities are discussed. Practical guidelines are given to the introduction of oral antidiabetic therapy, and the importance of the early, aggressive, combined treatment with a complex mechanism of action is emphasized.",
author = "G. Winkler and Eva Baranyi",
year = "2002",
month = "10",
day = "27",
language = "Hungarian",
volume = "143",
pages = "2441--2447",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "43",

}

TY - JOUR

T1 - Primeren kombinált oralis antidiabetikus terápia 2-es típusú diabetes mellitusban.

AU - Winkler, G.

AU - Baranyi, Eva

PY - 2002/10/27

Y1 - 2002/10/27

N2 - New target values of the metabolic control and recent directions in the therapeutic strategies of type 2 diabetes mellitus are overviewed. Attention is called to the atherogenic effect of blood glucose elevations exceeding physiological level, even when only post-prandial and with short duration. The significance of early phase prandial insulin secretion in the metabolic state is underlined, and the related new therapeutic possibilities are discussed. Practical guidelines are given to the introduction of oral antidiabetic therapy, and the importance of the early, aggressive, combined treatment with a complex mechanism of action is emphasized.

AB - New target values of the metabolic control and recent directions in the therapeutic strategies of type 2 diabetes mellitus are overviewed. Attention is called to the atherogenic effect of blood glucose elevations exceeding physiological level, even when only post-prandial and with short duration. The significance of early phase prandial insulin secretion in the metabolic state is underlined, and the related new therapeutic possibilities are discussed. Practical guidelines are given to the introduction of oral antidiabetic therapy, and the importance of the early, aggressive, combined treatment with a complex mechanism of action is emphasized.

UR - http://www.scopus.com/inward/record.url?scp=18744429829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18744429829&partnerID=8YFLogxK

M3 - Article

VL - 143

SP - 2441

EP - 2447

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 43

ER -